Hemocoagulase acutus (SCCIP/Rexan Pharamaceutical/Guangdong Sincody Pharmaceutical Development)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHemocoagulase acutus (SCCIP/Rexan Pharamaceutical/Guangdong Sincody Pharmaceutical Development)
Drug Alias NameKelining
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionFibrinogen modulatorsBlood coagulation pathway activation
TargetsFibrinogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSouth China Center For Innovative Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesRexan PharamaceuticalSouth China Center For Innovative PharmaceuticalsGuangdong Sincody Pharmaceutical Development Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A